CN Patent

CN102548579A — S1p受体调节剂的给药方案

Assigned to Novartis AG · Expires 2012-07-04 · 14y expired

What this patent protects

本发明依据提供了有益的收益-风险表现的给药方案，施用S1P受体调节剂。

USPTO Abstract

本发明依据提供了有益的收益-风险表现的给药方案，施用S1P受体调节剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN102548579A
Jurisdiction
CN
Classification
—
Expires
2012-07-04
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.